The CPT Editorial Panel has updated the Current Procedural Terminology (CPT®) code set to include a new administration code that is unique to a potential third dose of the current COVID-19 vaccine offered by Pfizer.
The provisional CPT code will be valid for use on the condition that a third dose shot of the Pfizer COVID-19 vaccine receives regulatory approval or authorization from the U.S. Food and Drug Administration (FDA).
The FDA and the CDC have analyzed data indicating that, at this time, individuals do not need to exceed the standard two doses authorized for Pfizer’s COVID-19 vaccine. These federal health agencies will continue to review emerging evidence on a potential third dose of the Pfizer COVID-19 vaccine.
The vaccine administration CPT code and long descriptor assigned to the third dose of the current Pfizer COVID-19 vaccine is:
0003A Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, diluent reconstituted; third dose